Matthew Stenerson

Title: Matthew Stenerson: Innovator in Insulin Pump Technology

Introduction

Matthew Stenerson, an inventor based in Daly City, California, has made significant contributions to the field of medical technology. With a singular patent to his name, Stenerson has focused on developing innovative methods for enhancing insulin delivery systems, which are vital for individuals managing diabetes.

Latest Patents

Stenerson's noteworthy patent is titled "Kalman filter based on-off switch for insulin pump." This invention introduces techniques for controlling insulin pumps by utilizing advanced predictive algorithms. The invention encompasses determining essential parameters, including a prediction time horizon, a glucose threshold for operation, and implementing a safety rule based on these factors. The Kalman filter helps process noisy glucose readings to accurately predict future glucose levels, ensuring timely shut-offs of the insulin pump when necessary. This innovation represents a significant step forward in diabetes management, offering enhanced safety and control for users.

Career Highlights

Throughout his career, Stenerson has contributed his expertise to reputable institutions, notably including Leland Stanford Junior University and The Regents of the University of California. These experiences have allowed him to develop and refine his innovative ideas, leading to his successful patent.

Collaborations

Stenerson has worked closely with esteemed colleagues in the field. Notable collaborators include Bruce A. Buckingham and B. Wayne Bequette, who have contributed to the development and testing of innovative medical technology. These collaborations underscore the interdisciplinary approach necessary for advancing healthcare solutions.

Conclusion

Matthew Stenerson's work exemplifies the spirit of innovation within the medical technology sector. His patent for the Kalman filter-based insulin pump switch highlights the critical intersection of engineering and healthcare. As challenges in diabetes management continue to evolve, Stenerson's contributions will undoubtedly have a lasting impact on improving patient outcomes.